Credit Suisse’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2.7M Sell
97,264
-1,324
-1% -$29.4K ﹤0.01% 1658
2023
Q4
$1.9M Buy
98,588
+1,421
+1% +$25.7K ﹤0.01% 1919
2023
Q3
$1.57M Sell
97,167
-3,330
-3% -$59.1K ﹤0.01% 1981
2023
Q2
$1.91M Buy
100,497
+10,302
+11% +$184K ﹤0.01% 1940
2023
Q1
$1.31M Sell
90,195
-12,778
-12% -$229K ﹤0.01% 2155
2022
Q4
$2.01M Buy
102,973
+18,010
+21% +$351K ﹤0.01% 1873
2022
Q3
$2.05M Sell
84,963
-8,567
-9% -$264K ﹤0.01% 1842
2022
Q2
$2.94M Buy
93,530
+2,613
+3% +$94.7K ﹤0.01% 1645
2022
Q1
$4M Buy
90,917
+34,370
+61% +$1.48M ﹤0.01% 1617
2021
Q4
$2.46M Sell
56,547
-1,968
-3% -$77.2K ﹤0.01% 2628
2021
Q3
$1.83M Sell
58,515
-7,277
-11% -$286K ﹤0.01% 2879
2021
Q2
$2.72M Sell
65,792
-7,085
-10% -$276K ﹤0.01% 2602
2021
Q1
$2.74M Sell
72,877
-3,156
-4% -$98.7K ﹤0.01% 2578
2020
Q4
$2.06M Buy
76,033
+26,506
+54% +$682K ﹤0.01% 2797
2020
Q3
$1.24M Buy
49,527
+4,374
+10% +$63.8K ﹤0.01% 2774
2020
Q2
$344K Buy
45,153
+9,219
+26% +$67.5K ﹤0.01% 3506
2020
Q1
$329K Sell
35,934
-22,649
-39% -$137K ﹤0.01% 3371
2019
Q4
$303K Buy
58,583
+45,338
+342% +$291K ﹤0.01% 3818
2019
Q3
$77K Sell
13,245
-231,387
-95% -$1.04M ﹤0.01% 3990
2019
Q2
$782K Buy
244,632
+183,129
+298% +$625K ﹤0.01% 3111
2019
Q1
$253K Sell
61,503
-12,945
-17% -$81.9K ﹤0.01% 3681
2018
Q4
$471K Buy
74,448
+13,258
+22% +$138K ﹤0.01% 3292
2018
Q3
$1.01M Sell
61,190
-14,614
-19% -$248K ﹤0.01% 2867
2018
Q2
$1.27M Buy
75,804
+1,924
+3% +$31.1K ﹤0.01% 2831
2018
Q1
$1.15M Buy
73,880
+343
+0.5% +$6.12K ﹤0.01% 2866
2017
Q4
$1.39M Sell
73,537
-37,208
-34% -$825K ﹤0.01% 2751
2017
Q3
$3.23M Buy
110,745
+37,800
+52% +$1.12M ﹤0.01% 2141
2017
Q2
$2.35M Sell
72,945
-616
-0.8% -$20.2K ﹤0.01% 2129
2017
Q1
$2.54M Sell
73,561
-31,752
-30% -$1.13M ﹤0.01% 2170
2016
Q4
$3.72M Buy
105,313
+15,192
+17% +$513K ﹤0.01% 1886
2016
Q3
$3.13M Sell
90,121
-41,833
-32% -$1.46M ﹤0.01% 2033
2016
Q2
$4.93M Buy
131,954
+54,952
+71% +$2.07M 0.01% 1630
2016
Q1
$3.11M Sell
77,002
-21,324
-22% -$794K ﹤0.01% 1867
2015
Q4
$3.54M Sell
98,326
-24,523
-20% -$887K ﹤0.01% 1858
2015
Q3
$3.92M Sell
122,849
-68,484
-36% -$2.33M ﹤0.01% 1745
2015
Q2
$6.51M Buy
191,333
+61,604
+47% +$2.08M 0.01% 1536
2015
Q1
$4.39M Sell
129,729
-8,155
-6% -$284K ﹤0.01% 1773
2014
Q4
$4.84M Sell
137,884
-7,817
-5% -$263K ﹤0.01% 1777
2014
Q3
$4.77M Sell
145,701
-38,261
-21% -$1.3M ﹤0.01% 1784
2014
Q2
$6.25M Sell
183,962
-19,796
-10% -$678K 0.01% 1751
2014
Q1
$7.14M Buy
203,758
+14,335
+8% +$506K 0.01% 1483
2013
Q4
$6.92M Buy
189,423
+45,745
+32% +$1.68M 0.01% 1562
2013
Q3
$4.97M Buy
143,678
+21,925
+18% +$767K ﹤0.01% 1641
2013
Q2
$4.12M Buy
+121,753
New +$4.04M ﹤0.01% 1730

Other funds holding ACH

Credit Suisse's ACH Position: Q1 2024 in Review

Credit Suisse reduced its Accendra Health (ACH) stake by 1.3% in Q1 2024, selling an estimated $29.4K and leaving 97,264 shares worth $2.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1658.

Credit Suisse first reported a position in ACH in Q2 2013 and has held it in 44 quarters since. The position peaked at $7.14M in Q1 2014. 231 funds tracked by Wall St. Rank hold ACH as of Q1 2024.

  • Credit Suisse held 97,264 shares of Accendra Health worth $2.7M as of Q1 2024.
  • Credit Suisse sold 1,324 Accendra Health shares in Q1 2024, an estimated $29.4K.
  • Accendra Health made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #1658 holding.
  • Credit Suisse first reported a position in Accendra Health in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Accendra Health position peaked at $7.14M in Q1 2014.
  • 231 funds tracked by Wall St. Rank held Accendra Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.